MEDS

DataMeds AI Inc. (MEDS) | Rumor.io

DataMeds AI

MEDS

Attention (50-day avg)0.01%

Attention rank (50-day avg)#584

Bullish sentiment (50-day avg)79%

Price to earnings ratio-0.05

Market capitalization12.2M

Earnings per share-48.3

Dividend yield (TTM)157.5%

Revenue (annual)23.3M

Net income (annual)-101.3M

Social

What share of all stock conversation is about MEDS?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% -0.02	0% -0.03	0.01% +0.01	0% +0

Sep 29

$MEDS has increased by 3000 at an average price of 3.835.
The stock is experiencing a short-term upward trend, but currently experiencing a correction phase.
The current support level is $3, with a bearish target of $1.62 if the trend reverses.

Generated by AI

Sentiment

Of the messages about MEDS that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	60% -17.5	75.81% -1.95	78.6% -9.79	74.35% +1.73
Bearish	40% +17.5	24.19% +1.95	21.4% +9.79	25.65% -1.73

Bullish· Sep 28

$MEDS is expected to break through to $4.50, and potentially reach $6, with a target of $8-$9 if momentum is maintained.
The stock has a strong potential for a large gain, with one user aiming to make their shares scarce and another having already profited $5K+.
The stock's charts are trending up, with a breakout of the downtrend line and a gap that could lead to a lift off to double digits.

Bearish· Sep 28

The asset's price has been declining, with some users selling their shares at a relatively low price, indicating a lack of confidence in the stock.
The short positions in the asset are starting to fail, and there is a possibility that the stock may bounce back to its previous price above $4.66.
The asset is experiencing low trading volumes and a lack of momentum, with some users expressing concerns that the stock may continue to decline or even "blow" in value.

Generated by AI

Topics

Of the messages about MEDS that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	0%	85.07%	50.2%	56.47%
Technical Analysis	100%	14.93%	46%	37.77%
Controversies	0%	0%	3.8%	5.04%
Analysts	0%	0%	0%	0%
Earnings	0%	0%	0%	0.72%
Macro	0%	0%	0%	0%

Announcements· Mar 25

$MEDS (TRxADE HEALTH, Inc.) is trending on March 25, 2024.
No specific market-relevant information is provided.
No further announcements or details are mentioned in the post.

Technical Analysis· Sep 16

$MEDS is exhibiting a double bottom bounce, potentially leading to a price increase to $5+.
The stock has shown strength, with a 67% gain from the first alert, and is currently holding at $10.26, with a relative volume of 1.1 and RSI of 83.
$MEDS is forming a bull flag on the 15-minute chart, with two red candles followed by two green, and is also curling up towards pre-market highs, potentially setting up for a trade.

Generated by AI

Community

Of the messages about MEDS, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	52%	22.93%	18.19%	6.94%
Newcomers	48%	77.07%	81.81%	93.06%

Regulars· Sep 28

MEDS has introduced a Health Lives Here mobile app to support GLP-1 users, backed by an NFL Alumni Health partnership, which could have a positive impact on the company's offerings.
The stock has shown a strong low-risk day trade setup, with a potential to break above $4.50 and reach $5 or $6, supported by a keybreak at $4.66 and significant trading volume.
MEDS has reported a high of $4.87, indicating a strong close, and some participants are optimistic about the stock's potential to continue rising, with one user expressing excitement and another expressing hope for continued growth.

Newcomers· Sep 29

The price of MEDS has increased by 3000, with an average price of 3.835, and some users are optimistic about the stock's future, with one user predicting it will reach 6.29.
Some users are concerned about the low float of MEDS, with one user mentioning it's just 10$, which could lead to significant price movements.
Users are discussing the stock's recent performance, with one user noting a bearish target was reached and another user warning about the bot selling shares to itself, which could artificially lower the price.

Generated by AI

Also Discussed

Investors talking about MEDS also mention

#	Name	Attention
1	Ainos, Inc.AIMD	0%+0
2	Veea Inc.VEEA	0%0
3	Scienture Holdings, Inc.SCNX	0%0
4	CleanCore Solutions Inc. Class B Common StockZONE	0%+0
5	GCL Global Holdings LtdGCL	0%0
6	BIO-key International, Inc.BKYI	0.08%+0.08
7	Generation Income Properties Inc.GIPR	0%0
8	BeneficientBENF	0.01%+0
9	Linkers Industries LimitedLNKS	0%0
10	TNL Mediagene Ordinary SharesTNMG	0%new

DataMeds AI Inc.

Healthcare
Medical Distribution

DataMeds AI Inc. is a healthcare technology and pharmaceutical logistics company that focuses on integrating pharmacy operations, digital health infrastructure, and health information tools. The company provides technology-driven solutions that support prescription fulfillment, pharmacy coordination, clinical services, and healthcare data workflows across the drug supply chain. Its current platform combines artificial intelligence and blockchain-enabled smart contract capabilities to streamline interactions among pharmacies, providers, manufacturers, and payors. DataMeds AI also operates across pharmacy services, wholesale distribution, and telemedicine-adjacent business units, with an emphasis on improving access, transparency, and operational efficiency in healthcare delivery. The company serves as a bridge between clinical care and pharmaceutical commerce, positioning its products and services within the broader health IT and pharmaceutical services markets.

Website

Location

3000 Bayport Drive

Tampa, FL, 33607

United States

Social

What share of all stock conversation is about MEDS?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% -0.02	0% -0.03	0.01% +0.01	0% +0

Sep 29

$MEDS has increased by 3000 at an average price of 3.835.
The stock is experiencing a short-term upward trend, but currently experiencing a correction phase.
The current support level is $3, with a bearish target of $1.62 if the trend reverses.

Generated by AI

Sentiment

Of the messages about MEDS that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	60% -17.5	75.81% -1.95	78.6% -9.79	74.35% +1.73
Bearish	40% +17.5	24.19% +1.95	21.4% +9.79	25.65% -1.73

Bullish· Sep 28

$MEDS is expected to break through to $4.50, and potentially reach $6, with a target of $8-$9 if momentum is maintained.
The stock has a strong potential for a large gain, with one user aiming to make their shares scarce and another having already profited $5K+.
The stock's charts are trending up, with a breakout of the downtrend line and a gap that could lead to a lift off to double digits.

Bearish· Sep 28

The asset's price has been declining, with some users selling their shares at a relatively low price, indicating a lack of confidence in the stock.
The short positions in the asset are starting to fail, and there is a possibility that the stock may bounce back to its previous price above $4.66.
The asset is experiencing low trading volumes and a lack of momentum, with some users expressing concerns that the stock may continue to decline or even "blow" in value.

Generated by AI

Topics

Of the messages about MEDS that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	0%	85.07%	50.2%	56.47%
Technical Analysis	100%	14.93%	46%	37.77%
Controversies	0%	0%	3.8%	5.04%
Analysts	0%	0%	0%	0%
Earnings	0%	0%	0%	0.72%
Macro	0%	0%	0%	0%

Announcements· Mar 25

$MEDS (TRxADE HEALTH, Inc.) is trending on March 25, 2024.
No specific market-relevant information is provided.
No further announcements or details are mentioned in the post.

Technical Analysis· Sep 16

$MEDS is exhibiting a double bottom bounce, potentially leading to a price increase to $5+.
The stock has shown strength, with a 67% gain from the first alert, and is currently holding at $10.26, with a relative volume of 1.1 and RSI of 83.
$MEDS is forming a bull flag on the 15-minute chart, with two red candles followed by two green, and is also curling up towards pre-market highs, potentially setting up for a trade.

Generated by AI

Community

Of the messages about MEDS, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	52%	22.93%	18.19%	6.94%
Newcomers	48%	77.07%	81.81%	93.06%

Regulars· Sep 28

MEDS has introduced a Health Lives Here mobile app to support GLP-1 users, backed by an NFL Alumni Health partnership, which could have a positive impact on the company's offerings.
The stock has shown a strong low-risk day trade setup, with a potential to break above $4.50 and reach $5 or $6, supported by a keybreak at $4.66 and significant trading volume.
MEDS has reported a high of $4.87, indicating a strong close, and some participants are optimistic about the stock's potential to continue rising, with one user expressing excitement and another expressing hope for continued growth.

Newcomers· Sep 29

The price of MEDS has increased by 3000, with an average price of 3.835, and some users are optimistic about the stock's future, with one user predicting it will reach 6.29.
Some users are concerned about the low float of MEDS, with one user mentioning it's just 10$, which could lead to significant price movements.
Users are discussing the stock's recent performance, with one user noting a bearish target was reached and another user warning about the bot selling shares to itself, which could artificially lower the price.

Generated by AI

DataMeds AI

Social

Sep 29

Sentiment

Bullish· Sep 28

Bearish· Sep 28

Topics

Announcements· Mar 25

Technical Analysis· Sep 16

Community

Regulars· Sep 28

Newcomers· Sep 29

Also Discussed

DataMeds AI Inc.

Company Information

Location

Also Discussed

Social

Sep 29

Sentiment

Bullish· Sep 28

Bearish· Sep 28

Topics

Announcements· Mar 25

Technical Analysis· Sep 16

Community

Regulars· Sep 28

Newcomers· Sep 29